Literature DB >> 6341013

Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy.

P Arner, R Gunnarsson, S Blomdahl, C G Groth.   

Abstract

Risk factors and course of steroid diabetes were investigated in 145 renal-transplant recipients who were given a high-dose steroid regimen. Persistent steroid diabetes developed in 25% of the patients and transient diabetes in another 22%. When antidiabetic therapy was required, insulin had to be given in 50%. The incidence of steroid diabetes correlated with steroid dose, age, body weight, and diabetes heredity but not with abnormal glucose tolerance or with another complication of steroid therapy, posterior-pole lenticular cataract. There was no association with HLA-A and B antigens. Thus, steroid diabetes is a frequent complication of high-dose corticosteroid therapy and is similar to type II diabetes. However, it often requires insulin therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341013     DOI: 10.2337/diacare.6.1.23

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  28 in total

1.  Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease.

Authors:  Seo Yun Kim; Chul-Gyu Yoo; Chun Taeg Lee; Hee Soon Chung; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

2.  Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis.

Authors:  Robin Winkler; Verena Benz; Markus Clemenz; Mandy Bloch; Anna Foryst-Ludwig; Sami Wardat; Nicole Witte; Manuela Trappiel; Pawel Namsolleck; Knut Mai; Joachim Spranger; Gabriele Matthias; Tim Roloff; Oliver Truee; Kai Kappert; Michael Schupp; Patrick Matthias; Ulrich Kintscher
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

Review 3.  Natural history and epidemiology of post transplantation diabetes mellitus.

Authors:  Olutayo C Alebiosu; Olugbenga E Ayodele
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 4.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

5.  Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation.

Authors:  H A Chakkera; R L Hanson; S M Raza; J K DiStefano; M P Millis; R L Heilman; D C Mulligan; K S Reddy; M J Mazur; K Hamawi; A A Moss; K L Mekeel; J R Cerhan
Journal:  Transplant Proc       Date:  2009-12       Impact factor: 1.066

6.  Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

Authors:  Olwyn Johnston; Caren L Rose; Angela C Webster; John S Gill
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 7.  Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?

Authors:  Fu L Luan; Diane E Steffick; Akinlolu O Ojo
Journal:  Kidney Int       Date:  2009-07-22       Impact factor: 10.612

8.  Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy.

Authors:  Suk-Young Lee; Naoki Kurita; Yasuhisa Yokoyama; Masanori Seki; Yuichi Hasegawa; Yasushi Okoshi; Shigeru Chiba
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

Review 9.  Diagnosis and approach to posttransplant diabetes.

Authors:  Vittoria Bonato; Dorica Cataldo; Francesco Dotta; Mario Carmellini
Journal:  Curr Diab Rep       Date:  2009-08       Impact factor: 4.810

10.  Alternate day corticosteroid causes alternate day hyperglycaemia.

Authors:  M A Greenstone; A B Shaw
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.